Friday, April 16, 2021

Experimental antiviral for COVID-19 effective in hamster study

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study. MK-4482, delivered orally, is now in human clinical trials.

from Top Health News -- ScienceDaily https://ift.tt/3wXH0Hj

No comments:

Post a Comment

This “master gene” may be driving pancreatic cancer’s spread

A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DN...